logo
episode-header-image
Feb 2024
22m 46s

The obesity drug craze is entering its n...

Reuters
About this episode

Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection practices. You may also visit megaphone.fm/adchoices to opt-out of targeted advertising.

Up next
Jul 3
Nippon Steel deal reveals cost of ‘America First’
The Japanese steelmaker pushed its $14.9 bln bid for United States Steel past the line with some big concessions. In this Viewsroom podcast, Breakingviews columnists debate the golden share it handed to the US government and what this means for others eyeing stateside expansion. 
20m 23s
Jun 26
US IPO bounty may be tricky to duplicate
CoreWeave, Circle Internet Group and Chime Financial all enjoyed dizzying success after their stock market debuts. In this Viewsroom podcast, Breakingviews columnists explain why investors are scrambling to own these companies and how scarcity may be adding to their allure. Visit ... Show More
17m 15s
Jun 12
Elon Musk has a lot to lose in Trump brawl
The Tesla and SpaceX billionaire boiled over with criticism of the US president after leaving his government cost-slashing role. In this Viewsroom podcast, Breakingviews columnists debate the tale of the tape for the bruising bust-up. Visit the Thomson Reuters Privacy Statement f ... Show More
25m 36s
Recommended Episodes
May 2024
Protectionism - Listen to episode 1 of Reuters Econ World
Listen to the first episode of our new podcast. Host Carmel Crimmins and China bureau chief Kevin Krolicki discuss recent moves by the US to impose tariffs on China’s hot industry – EVs. What is protectionism versus good local policy, how have we arrived at this point, and what d ... Show More
23m 44s
Apr 2024
Money Talks: Why weight-loss drugs will reshape the world
More than 1bn people around the world are obese. That means there should be extraordinary demand for drugs to cure or mitigate the condition. Novo Nordisk is now Europe’s most valuable company and Eli Lilly’s market value has more than doubled. Both make the “miracle” drugs that ... Show More
36m 59s
May 2024
New Caledonia riots, Lael Brainard interview and Blinken’s rock performance
Riots rage in New Caledonia, as France approves changes to voting rules in the French territory. President Biden’s top economic adviser – Lael Brainard – joins the Reuters World News podcast for an interview, as the US hits China with steep tariffs. Plus, Secretary of State Anton ... Show More
12m 45s
May 2024
Deadly flight turbulence, China's weight loss market and Kenya’s Haiti deployment
Passengers are left shaken after severe turbulence hit a Singapore Airlines flight. Eli Lilly’s diabetes drug wins approval in China, intensifying weight loss drugmakers’ competition in the Asian market. And a Kenyan police deployment to Haiti to help combat gang violence is immi ... Show More
12m 38s
Apr 2024
The truth is out there: the Peruvian grave robbings at the center of ‘alien’ claims
Two small fossilized corpses were presented in Mexico as a sign of life beyond Earth - join Reuters journalist Cassandra Garrison on a journey for the truth through Peru’s illegal artifact trade. Audio clips from ABC7, The Stephen Colbert Show, and WION.Visit the Thomson Reuters ... Show More
20m 3s
Apr 2024
Trump’s trials, Powell’s warning and geopolitics at the Olympics
The Supreme Court hears a January 6th case with implications for Donald Trump. Fed Chair Jerome Powell’s hawkish turn on interest rates raises the stakes for poor countries seeking debt relief. And with 100 days to go until the Olympics in Paris, global tensions hang over the Gam ... Show More
12m 12s
Sep 2023
Speed dating for diplomats: An inside guide to the UN General Assembly
The UN General Assembly meets in New York this week with a backdrop of war and increasingly fragmented world. On this special episode, we talk to our journalists around the world about what to expect during the gathering, and whether this storied body can actually get anything ac ... Show More
17m 1s
Apr 2023
Counting the cost of the US-China chip war
Six months into Washington’s sweeping export restrictions on semiconductors, Chinese and global chipmakers including TSMC are navigating the fallout. In this Exchange podcast, author Chris Miller talks about the fight for the critical technology and how Beijing may retaliate.Visi ... Show More
27m 27s
Jun 2024
France’s snap election and the rise of the far right
President Emmanuel Macron launched a risky political gamble by calling a snap legislative election after his centrist party’s poor performance in European polls. In this special edition of Reuters World News podcast, we look at how youth support has bolstered the far right – and ... Show More
23m 1s
Sep 2021
After Hours: America's Medicine Cabinet
Puerto Rico's newest business initiative might not only help them get out of financial crisis, it could impact all of us by helping America quit its unwise addiction to medicine made in China. Subscribe to my two podcasts: “The Sharyl Attkisson Podcast” and “Full Measure After Ho ... Show More
32m 45s